UroGen Pharma Ltd. (URGN) Stock Price History
Historical prices from 2017 to 2026
Loading 10-year price history...
URGN Historical Performance
Short-Term Returns
URGN Stock Price Trajectory (2017–2026)
As of May 8, 2026, UroGen Pharma Ltd. (URGN) trades at $26.59, representing a +162.7% return over the past year. The stock has delivered a +45.9% total return over five years (+7.9% CAGR), reflecting significant long-term value creation.
The stock reached its all-time high of $69.57 on May 21, 2018. From this peak, URGN has corrected -61.8%, currently trading 29% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers PCVX (+77.5% 1Y), SUPN (+69.0% 1Y), and PRGO (-55.6% 1Y), URGN has outperformed the peer group average. Compare URGN vs PCVX →
URGN Historical Price Data (2025–2026)
Showing 30 of 2,266 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 27.33 | 27.33 | 24.57 | 26.59 | 1.33M | +1.30% |
| 2026-05-06 | 25.22 | 27.43 | 23.63 | 26.25 | 2.72M | +10.16% |
| 2026-05-05 | 23.33 | 23.88 | 22.99 | 23.83 | 746K | +2.32% |
| 2026-05-04 | 23.20 | 23.64 | 22.69 | 23.29 | 618K | +1.26% |
| 2026-05-01 | 23.65 | 24.42 | 22.91 | 23.00 | 795K | -3.48% |
| 2026-04-30 | 23.57 | 23.98 | 23.11 | 23.83 | 378K | +2.10% |
| 2026-04-29 | 24.01 | 24.28 | 23.17 | 23.34 | 475K | -3.23% |
| 2026-04-28 | 23.85 | 24.58 | 22.61 | 24.12 | 467K | +1.47% |
| 2026-04-27 | 24.33 | 25.00 | 23.63 | 23.77 | 413K | -1.41% |
| 2026-04-24 | 24.56 | 24.60 | 23.79 | 24.11 | 551K | -0.82% |
| 2026-04-23 | 26.41 | 26.55 | 23.78 | 24.31 | 871K | -6.72% |
| 2026-04-22 | 25.48 | 27.76 | 25.37 | 26.06 | 1.73M | +4.12% |
| 2026-04-21 | 24.99 | 25.81 | 24.41 | 25.03 | 1.10M | +0.44% |
| 2026-04-20 | 22.69 | 24.94 | 22.07 | 24.92 | 1.21M | +10.56% |
| 2026-04-17 | 22.02 | 22.70 | 22.00 | 22.54 | 589K | +5.38% |
| 2026-04-16 | 21.49 | 22.52 | 21.25 | 21.39 | 976K | -0.56% |
| 2026-04-15 | 20.86 | 21.53 | 20.65 | 21.51 | 809K | +1.37% |
| 2026-04-14 | 20.45 | 21.65 | 20.42 | 21.22 | 597K | +4.64% |
| 2026-04-13 | 21.53 | 21.89 | 20.09 | 20.28 | 670K | -5.96% |
| 2026-04-10 | 21.40 | 22.02 | 20.54 | 21.57 | 1.05M | +5.04% |
| 2026-04-09 | 18.96 | 20.61 | 18.70 | 20.53 | 1.09M | +7.49% |
| 2026-04-08 | 19.09 | 19.55 | 18.25 | 19.10 | 803K | +5.91% |
| 2026-04-07 | 18.45 | 18.58 | 17.75 | 18.03 | 493K | -3.10% |
| 2026-04-06 | 19.14 | 19.42 | 18.61 | 18.61 | 433K | -1.12% |
| 2026-04-02 | 18.49 | 19.20 | 18.44 | 18.82 | 367K | -0.63% |
| 2026-04-01 | 18.18 | 18.98 | 18.11 | 18.94 | 489K | +5.34% |
| 2026-03-31 | 17.36 | 18.52 | 17.34 | 17.98 | 672K | +5.76% |
| 2026-03-30 | 17.00 | 17.19 | 16.61 | 17.00 | 1.04M | -0.99% |
| 2026-03-27 | 17.90 | 18.13 | 17.05 | 17.17 | 809K | -4.08% |
| 2026-03-26 | 17.88 | 18.16 | 17.66 | 17.90 | 303K | -1.21% |
See URGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs URGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare URGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonURGN — Frequently Asked Questions
Quick answers to the most common questions about buying URGN stock.
How has URGN stock performed recently?
URGN returned +162.7% over the past year, beating its 5-year annualized CAGR of +7.9%. The stock trades above its 200-day moving average, confirming the uptrend.
What is URGN's all-time high price?
UroGen Pharma Ltd. reached $69.57 on 2018-05-21. The 52-week high is $30.00. Current 1-year return of +162.7% places the stock closer to historical peaks.
Where can I download URGN historical price data?
This page provides URGN daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2017-2026, downloadable in CSV format.